Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa.

COVID-19 vaccine SARS-CoV-2 adverse events following immunisation (AEFI) public health vaccination vaccine adverse events

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
01 Apr 2022
Historique:
received: 28 01 2022
revised: 09 03 2022
accepted: 21 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Local, national, and international health agencies have advocated multi-pronged public health strategies to limit infections and prevent deaths. The availability of safe and effective vaccines is critical in the control of a pandemic. Several adverse events have been reported globally following reception of different vaccines, with limited or no data from Africa. This cross-sectional epidemiological study investigated adverse events following COVID-19 vaccination in Africans from April-June, 2021 using a structured online questionnaire. Out of 1200 participants recruited, a total of 80.8% (

Identifiants

pubmed: 35455295
pii: vaccines10040546
doi: 10.3390/vaccines10040546
pmc: PMC9032114
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Vaccines (Basel). 2019 Oct 07;7(4):
pubmed: 31591347
BMC Pharmacol Toxicol. 2021 Oct 12;22(1):58
pubmed: 34641944
Ann Ig. 2022 Feb 03;:
pubmed: 35107123
AJR Am J Roentgenol. 2021 Oct;217(4):831-834
pubmed: 33543649
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2658-2668.e3
pubmed: 33711496
J Korean Med Sci. 2021 May 03;36(17):e114
pubmed: 33942578
PLoS One. 2021 Dec 1;16(12):e0260575
pubmed: 34851998
Toxicol Rep. 2021;8:871-879
pubmed: 33898273
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet Infect Dis. 2021 Jul;21(7):939-949
pubmed: 33930320
Cell Death Differ. 2021 Feb;28(2):626-639
pubmed: 33479399
Allergo J Int. 2021;30(2):51-55
pubmed: 33643776
JAMA. 2021 Oct 12;326(14):1390-1399
pubmed: 34477808
Front Immunol. 2021 Aug 13;12:728513
pubmed: 34484238
Psychol Bull. 2001 Mar;127(2):267-86
pubmed: 11316014
Expert Rev Vaccines. 2021 Aug;20(8):1037-1042
pubmed: 34092166
Arch Public Health. 2021 Nov 24;79(1):207
pubmed: 34819146
J Gen Intern Med. 2015 Mar;30(3):290-7
pubmed: 25387439
Trop Med Int Health. 2021 Jan;26(1):2-13
pubmed: 33012053
Vaccines (Basel). 2021 Dec 31;10(1):
pubmed: 35062719
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Lancet Infect Dis. 2021 Feb;21(2):181-192
pubmed: 33217362
JAMA Intern Med. 2021 Sep 1;181(9):1243-1245
pubmed: 33904857

Auteurs

AbdulAzeez Adeyemi Anjorin (AA)

Department of Microbiology (Virology Research), Lagos State University, Ojo 102101, Lagos, Nigeria.

Ismail A Odetokun (IA)

Department of Veterinary Public Health & Preventive Medicine, University of Ilorin, Ilorin 200213, Kwara State, Nigeria.

Jean Baptiste Nyandwi (JB)

Department of Pharmacy, University of Rwanda, Kigali 4285, Rwanda.

Hager Elnadi (H)

Infectious Diseases and One Health Department, Universite de Tours, 37000 Tours, France.

Kwame Sherrif Awiagah (KS)

Training and Research Unit, Korle Bu Teaching Hospital, Accra P.O. Box KB 77, Ghana.

Joseph Eyedo (J)

Department of Microbiology (Virology Research), Lagos State University, Ojo 102101, Lagos, Nigeria.

Ajibola Ibraheem Abioye (AI)

Department of Nutrition, Harvard University, Boston, MA 01451, USA.

George Gachara (G)

Department of Medical Laboratory Science, Kenyatta University, Nairobi 00609, Kenya.

Aala MohmedOsman Maisara (AM)

Department of Nephrology and Hemodialysis Center, Bahre Teaching Hospital and Faculty of Medicine, International University of Africa, Khartoum 12223, Sudan.

Youssef Razouqi (Y)

Laboratory of Biological Engineering, Faculty of Science and Technology, Sultan Moulay Slimane University, Mghilla Campus, BP 523, Beni Mellal 23000, Morocco.

Mohamed Farah Yusuf Mohamud (MF)

Mogadishu Somali Turkish Training and Research Hospital, Mogadishu 2526, Somalia.

Zuhal Ebrahim Mhgoob (ZE)

Department of Infection Control, Al Jawad Hospital, Khartoum 11111, Sudan.

Tunde Ajayi (T)

Lagos State Ministry of Health, Ikeja 100271, Lagos, Nigeria.

Lazare Ntirenganya (L)

Pharmacovigilance and Safety Monitoring Division, Rwanda Food and Drugs Authority, Kigali P.O. Box 1948, Rwanda.

Morounke Saibu (M)

Department of Biochemistry, Lagos State University, Ojo 102101, Lagos, Nigeria.
Walter Sisulu University, Mthatha Campus, Mthatha 5117, South Africa.

Babatunde Lawal Salako (BL)

Department of Medicine, University of Ibadan, Ibadan 200132, Oyo State, Nigeria.
Office of the Director General, Nigerian Institute of Medical Research, Yaba, Lagos 101212, Lagos, Nigeria.

Nusirat Elelu (N)

Department of Veterinary Public Health & Preventive Medicine, University of Ilorin, Ilorin 200213, Kwara State, Nigeria.
Kwara State COVID-19 Technical Working Group, Ilorin 240241, Kwara State, Nigeria.

Kikelomo Ololade Wright (KO)

Department of Community Health and Primary Health Care, Lagos State University College of Medicine, Ikeja 100271, Lagos, Nigeria.
Lagos State University Teaching Hospital, Ikeja 100271, Lagos, Nigeria.

Folorunso O Fasina (FO)

Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agricultural Organization of the United Nations (FAO), Nairobi 00100, Kenya.
Department of Veterinary Tropical Diseases, University of Pretoria, Pretoria 0182, South Africa.

Rasha Mosbah (R)

Infection Control Unit, Zagazig University Hospitals, Zagazig 44511, Egypt.
Faculty of Oral and Dental Medicine, Ahram Canadian University, Giza 12578, Egypt.

Classifications MeSH